Logo image of CJET

CHIJET MOTOR CO INC (CJET) Stock Fundamental Analysis

USA - NASDAQ:CJET - KYG4465R1112 - Common Stock

0.0983 USD
+0.02 (+21.51%)
Last: 10/22/2025, 5:31:09 PM
0.1009 USD
+0 (+2.64%)
After Hours: 10/22/2025, 5:31:09 PM
Fundamental Rating

0

Overall CJET gets a fundamental rating of 0 out of 10. We evaluated CJET against 36 industry peers in the Automobiles industry. CJET has a bad profitability rating. Also its financial health evaluation is rather negative. CJET has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CJET had negative earnings in the past year.
In the past year CJET has reported a negative cash flow from operations.
CJET Yearly Net Income VS EBIT VS OCF VS FCFCJET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

CJET's Return On Assets of -9.96% is in line compared to the rest of the industry. CJET outperforms 58.33% of its industry peers.
Industry RankSector Rank
ROA -9.96%
ROE N/A
ROIC N/A
ROA(3y)-7.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CJET Yearly ROA, ROE, ROICCJET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

CJET does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CJET Yearly Profit, Operating, Gross MarginsCJET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

CJET does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CJET has more shares outstanding
CJET has a worse debt/assets ratio than last year.
CJET Yearly Shares OutstandingCJET Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
CJET Yearly Total Debt VS Total AssetsCJET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

CJET has an Altman-Z score of -2.73. This is a bad value and indicates that CJET is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.73, CJET is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.73
ROIC/WACCN/A
WACC2.25%
CJET Yearly LT Debt VS Equity VS FCFCJET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

A Current Ratio of 0.11 indicates that CJET may have some problems paying its short term obligations.
With a Current ratio value of 0.11, CJET is not doing good in the industry: 94.44% of the companies in the same industry are doing better.
A Quick Ratio of 0.09 indicates that CJET may have some problems paying its short term obligations.
CJET has a worse Quick ratio (0.09) than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.09
CJET Yearly Current Assets VS Current LiabilitesCJET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

0

3. Growth

3.1 Past

CJET shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.88%, which is quite impressive.
CJET shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.08%.
EPS 1Y (TTM)31.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.88%
Revenue 1Y (TTM)-27.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.08%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CJET Yearly Revenue VS EstimatesCJET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CJET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJET Price Earnings VS Forward Price EarningsCJET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CJET Per share dataCJET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CJET!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHIJET MOTOR CO INC

NASDAQ:CJET (10/22/2025, 5:31:09 PM)

After market: 0.1009 +0 (+2.64%)

0.0983

+0.02 (+21.51%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.15%
Inst Owner ChangeN/A
Ins Owners3.34%
Ins Owner ChangeN/A
Market Cap17.09M
Revenue(TTM)6.92M
Net Income(TTM)-46895000
AnalystsN/A
Price TargetN/A
Short Float %1.73%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.47
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.66
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.04
BVpS-1.03
TBVpS-2.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.96%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.7%
Cap/Sales 15.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.09
Altman-Z -2.73
F-Score3
WACC2.25%
ROIC/WACCN/A
Cap/Depr(3y)15.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.37%
OCF growth 3YN/A
OCF growth 5YN/A